Works matching IS 1021335X AND DT 2022 AND VI 47 AND IP 5

Results: 21

RETRACTION: Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma in vitro and in vivo.

Published in:

Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8297

By:

JIA LIU;
BING‑FEI DONG;
PEI‑SONG WANG;
PEI‑YOU REN;
SHUAI XUE;
XIAO‑ΝAN ZHANG;
ZHE HAN;
GUANG CHEN

Publication type:

Article

Dinaciclib inhibits the stemness of two subtypes of human breast cancer cells by targeting the FoxM1 and Hedgehog signaling pathway.

Published in:

Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8316

By:

AI-NI TSAO;
YU-SYUAN CHUANG;
YEN-CHUN LIN;
YEU SU;
TA-CHUNG CHAO

Publication type:

Article

Blue light irradiation inhibits the growth of colon cancer and activation of cancer-associated fibroblasts.

Published in:

Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8315

By:

TOSHIAKI YOSHIMOTO;
MITSUO SHIMADA;
TAKUYA TOKUNAGA;
TOSHIHIRO NAKAO;
MASAAKI NISHI;
CHIE TAKASU;
HIDEYA KASHIHARA;
YUMA WADA;
SHOHEI OKIKAWA;
KOZO YOSHIKAWA

Publication type:

Article

CORRIGENDUM.

Published in:: Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8314
Publication type:: Article

Tumor microenvironment manipulates chemoresistance in ovarian cancer (Review).

Published in:

Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8313

By:

QIAOLING ZHANG;
JIASHAN DING;
YINGMEI WANG;
LINSHENG HE;
FENGXIA XUE

Publication type:

Article

Research progress of anti-glioma chemotherapeutic drugs (Review).

Published in:

Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8312

By:

YI-SHU ZHOU;
WEI WANG;
NA CHEN;
LI-CUI WANG;
JIN-BAI HUANG

Publication type:

Article

CORRIGENDUM.

Published in:: Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8311
Publication type:: Article

TP53 loss-of-function mutations reduce sensitivity of acute leukaemia to the curaxin CBL0137.

Published in:

Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8310

By:

FORGIONE, MICHELLE O.;
McCLURE, BARBARA J.;
PAGE, ELYSE C.;
YEUNG, DAVID T.;
EADIE, LAURA N.;
WHITE, DEBORAH L.

Publication type:

Article

CORRIGENDUM.

Published in:: Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8309
Publication type:: Article

IFNγ enhances ferroptosis by increasing JAK-STAT pathway activation to suppress SLCA711 expression in adrenocortical carcinoma.

Published in:

Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8308

By:

XINBO YU;
DANDAN ZHU;
BIXIAN LUO;
WEI KOU;
YULING CHENG;
YU ZHU

Publication type:

Article

Regulatory functions of miR-200b-3p in tumor development (Review).

Published in:

Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8307

By:

SHENG CHEN;
YIFENG TU;
HANG YUAN;
ZHAN SHI;
YANG GUO;
WENJING GONG;
SHILIANG TU

Publication type:

Article

RETRACTION.

Published in:: Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8306
Publication type:: Article

Epithelial cell adhesion molecule-targeting designed ankyrin repeat protein-toxin fusion Ec1-LoPE exhibits potent cytotoxic action in prostate cancer cells.

Published in:

Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8305

By:

TIANQI XU;
YONGSHENG LIU;
SCHULGA, ALEXEY;
KONOVALOVA, ELENA;
DEYEV, SERGEY M.;
TOLMACHEV, VLADIMIR;
VOROBYEVA, ANZHELIKA

Publication type:

Article

Cancer therapy that targets the Hedgehog signaling pathway considering the cancer microenvironment (Review).

Published in:

Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8304

By:

HIDEYA ONISHI;
KATSUYA NAKAMURA;
KOSUKE YANAI;
SHUNTARO NAGAI;
KAZUNORI NAKAYAMA;
YASUHIRO OYAMA;
AKIKO FUJIMURA;
KEIGO OZONO;
AKIO YAMASAKI

Publication type:

Article

miRNA-218 targets multiple oncogenes and is a therapeutic target for osteosarcoma.

Published in:

Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8303

By:

KENTARO SATO;
EIJI OSAKA;
KYOKO FUJIWARA;
RYOTA FUJII;
TADATERU TAKAYAMA;
YASUAKI TOKUHASHI;
KAZUYOSHI NAKANISHI

Publication type:

Article

SPC25 promotes hepatocellular carcinoma metastasis via activating the FAK/PI3K/AKT signaling pathway through ITGB4.

Published in:

Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8302

By:

WEN-KAI SHI;
QIAO-LI SHANG;
YONG-FU ZHAO

Publication type:

Article

CORRIGENDUM.

Published in:: Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8301
Publication type:: Article

Levels of circulating mast cell progenitors and tumour-infiltrating mast cells in patients with colorectal cancer.

Published in:

Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8300

By:

PINGWEI ZHAO;
PEIWEN ZHOU;
TONGYU TANG;
RUI SI;
YIDING JI;
XINTONG HU;
ANG LI;
YANFANG JIANG

Publication type:

Article

Tetraspanin CD9: A friend or foe of head and neck cancer (Review).

Published in:

Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8299

By:

P. C., SUHASINI;
SHETTY, SHILPA S.;
NALILU, SUCHETHA KUMARI;
SHETTY, PRAVEEN KUMAR;
PATIL, PRAKASH

Publication type:

Article

Yin Yang 1 regulates ITGAV and ITGB1, contributing to improved prognosis of colorectal cancer.

Published in:

Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8298

By:

NAMI SATO;
NOZOMU SAKAI;
KATSUNORI FURUKAWA;
TSUKASA TAKAYASHIKI;
SATOSHI KUBOKI;
SHIGETSUGU TAKANO;
GAKU OHIRA;
HISAHIRO MATSUBARA;
MASAYUKI OHTSUKA

Publication type:

Article

RETRACTION.

Published in:: Oncology Reports, 2022, v. 47, n. 5, p. 1, doi. 10.3892/or.2022.8297
Publication type:: Article